Naslov
Antioxidant capacity in rat brain after ICV treatment with streptozotocin and alloxan – a preliminary study.

Autori
Sapcanin, Aida ; Sofic, Emin ; Tahirovic, Ismet ; Salkovic-Petrisic, Melita ; Hoyer, Siegfried ; Riederer, Peter

Izvornik
Neurotoxicity research (1029-8428) 13 (2008), 2; 97-104

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
antioxidant capacity; oxygen radical absorbance capacity ( ORAC ) assay; peroxyl radical; hydroxyl radical; oxidative stress; streptozotocin; alloxan; Alzheimer’ s disease

Sažetak
Intracerebroventricular ( icv ) administration of betacytotoxic drug streptozotocin ( STZ ) produces long-term and progressive cognitive deficits in rats, as well as deficits in cerebral glucose and energy metabolism. These changes resemble those found in the brain of patients with sporadic Alzheimer’ s disease ( sAD ), therefore STZ-icv treated rats have been proposed as an experimental model of sAD. In this study the antioxidant capacity ( AC ) using manual oxygen radical absorbance capacity ( ORAC ) assay was measured in the rat brain frontoparietal cortex ( FC ) and brainstem-cerebellum part ( BS-CB ) after administration of STZ and another betacytotoxic drug alloxan ( AL ). Region-specific differences of AC were found which were more expressed when hydroxyl radical ( ORAC-OH&ordm ; ) generator was used in the assay. AC against ORAC-OH&ordm ; was significantly lower in BS-CB than in FC of the control rats. ORAC-OH&ordm ; values significantly increased in FC 1 month after icv administration of STZ or combination of glucose transport inhibitor 5-thio-D-glucose +STZ in comparison with the controls. Furthermore, ORAC-OH&ordm ; significantly decreased in BS-CB 3 months following the icv administration of AL but significantly increased following the TG+AL combined treatment in comparison with the controls. However, 3 months following the icv treatment of AL combination with a different glucose transport inhbitor, 3-0-methyl-D-glucose, ORAC-OH&ordm ; values in BS-CB and ORAC-ROO&ordm ; values in FC were significantly decreased in comparison to the controls. Our results sugest that betacytotoxic-icv treatment alters antioxidative defense systems in the brain, which particularly regarding the STZ-icv treatment could be an useful tool in search for the possible new antioxidant treatments of the neurodegenerative disorders such as sAD.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti

POVEZANOST RADA